Oral Insulin Market Size, Share, Trends, Growth Outlook

The global Oral Insulin Market Size is estimated to register 34.6% growth over the forecast period from 2023 to 2030.

 

The market growth is driven by the increasing prevalence of diabetes globally is a significant driver for the oral insulin market. As the number of people with diabetes continues to grow, there is a greater demand for more convenient and effective insulin delivery methods. Leading companies that are focusing on Increasing Diabetes Burden, Advancements in Drug Delivery Technologies, Personalized Medicine, Regulatory Approvals, Improved Patient Compliance, and others to boost market shares in the industry.

 

Market Overview

The oral insulin market, a subset of the broader diabetes treatment sector, has shown promise in addressing the rising global diabetes prevalence and patient preference for non-injectable treatments. Key drivers include the growing diabetic population, technological advancements in drug delivery, regulatory support, and an aging demographic.

 

Market Dynamics

Market Trends- Impact of Increasing Research and Development on the Oral Insulin Market

Increasing research and development in the oral insulin sector is driving innovation, leading to more effective formulations, improved bioavailability, and enhanced stability. This innovation is making oral insulin a competitive alternative to injections and potentially streamlining regulatory approvals. It expands treatment options, increasing convenience, and improving patient outcomes in the diabetes market.

 

Market Driver- Growing Aging Population Demand for Oral Insulin Market

The growing aging population is fueling demand for the oral insulin market as older individuals, who are more susceptible to diabetes, seek convenient and non-invasive treatment options, making oral insulin a preferred choice and driving the market growth.

 

Market Opportunity-Introduction of Technological Advancements

Technological advancements in drug delivery methods, including nanoparticles and microneedles, are enhancing the effectiveness and reliability of oral insulin products. These innovations address challenges related to insulin delivery through the oral route, making oral insulin a competitive alternative to injections and expanding its market potential.

 

Market Share Analysis- Fast-acting insulin Oral Insulin Market will register the fastest growth.

The global Oral Insulin Market is analyzed across Fast-acting insulin, Intermediate-acting insulin, Long-acting insulin, and others. Of these, Fast-acting insulin is poised to register the fastest growth. Fast-acting oral insulin, driven by advancements in drug delivery technologies, offers a rapid response to blood glucose spikes, enhancing diabetes management for patients who prefer non-injectable options. This innovation presents a promising opportunity in the oral insulin market by providing a convenient and effective solution for better glycemic control.

 

Market Share Analysis- Online stores held a significant market share in 2023.

The global Oral Insulin Market is analyzed across a wide range of Distribution Channels including Online Stores, Hospitals Pharmacies, Retail Pharmacies, and others. Of these, Online Stores held a significant market share in 2023. Online stores for oral insulin products are gaining prominence in the market, providing convenient and accessible channels for patients and healthcare providers to purchase oral insulin medications and related supplies.

 

Oral Insulin Market Segmentation

By Drug Class

• Fast-acting insulin
• Intermediate-acting insulin
• Long-acting insulin

 

By Indications  

• Type 1 diabetes               
• Type 2 diabetes

 

By End User

• Adult
• Juvenile

 

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Store

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

 

Oral Insulin Market Companies

 

 

• Novo Nordisk A/S
• Oramed Pharmaceuticals Inc
• Eli Lilly and Company
• Coro Medical LLC
• Diabetology Ltd
• Biocon
• Wockhardt Ltd
• vTv Therapeutics
• Aradigm Corporation
• Nektar Therapeutics

 

* List not exhaustive

 

Oral Insulin Market Outlook 2023

1 Market Overview

1.1 Introduction to the Oral Insulin Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Oral Insulin Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Oral Insulin Market Companies with Area Served

4.2.2 Products Offerings Global Oral Insulin Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 Post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Oral Insulin Market Trends

6.1 Global Oral Insulin Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Oral Insulin Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Oral Insulin Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Oral Insulin Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Oral Insulin Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Oral Insulin Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Oral Insulin Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Oral Insulin Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Oral Insulin Development Regional Status and Outlook

8.1 Global Oral Insulin Revenue (USD Million) By Regions (2018-2022)

8.2 North America Oral Insulin Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Oral Insulin Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Oral Insulin Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Oral Insulin Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Oral Insulin Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Oral Insulin Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Oral Insulin Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Oral Insulin Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Oral Insulin Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Oral Insulin Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Oral Insulin Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Oral Insulin Revenue (USD Million) by Applications (2018-2022)

8.5 South America Oral Insulin Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Oral Insulin Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Oral Insulin Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Oral Insulin Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Oral Insulin Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Oral Insulin Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Oral Insulin Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Oral Insulin Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Oral Insulin Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Oral Insulin Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Oral Insulin Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Oral Insulin Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Oral Insulin Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Oral Insulin Development Regional Status and Outlook Forecast

11.1 Global Oral Insulin Revenue (USD Million) By Regions (2023-2030)

11.2 North America Oral Insulin Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Oral Insulin Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Oral Insulin Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Oral Insulin Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Oral Insulin Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Oral Insulin Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Oral Insulin Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Oral Insulin Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Oral Insulin Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Oral Insulin Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Oral Insulin Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Oral Insulin Revenue (USD Million), by Applications (2023-2030)

11.5 South America Oral Insulin Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Oral Insulin Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Oral Insulin Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Oral Insulin Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Oral Insulin Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Oral Insulin Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Oral Insulin Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Oral Insulin Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Oral Insulin Market Companies with Areas Served

Table 3 Products Offerings Global Oral Insulin Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Oral Insulin Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Oral Insulin Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Oral Insulin Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Oral Insulin Revenue (USD Million) By Type (2018-2022)

Table 11 Global Oral Insulin Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Oral Insulin Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Oral Insulin Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Oral Insulin Market Share (%) By Regions (2018-2022)

Table 16 North America Oral Insulin Revenue (USD Million) By Country (2018-2022)

Table 17 North America Oral Insulin Revenue (USD Million) By Type (2018-2022)

Table 18 North America Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Oral Insulin Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Oral Insulin Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Oral Insulin Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Oral Insulin Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Oral Insulin Revenue (USD Million) By Country (2018-2022)

Table 26 South America Oral Insulin Revenue (USD Million) By Type (2018-2022)

Table 27 South America Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Oral Insulin Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Oral Insulin Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Oral Insulin Revenue (USD Million) By Type (2023-2030)

Table 33 Global Oral Insulin Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Oral Insulin Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Oral Insulin Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Oral Insulin Revenue (USD)By Country (2023-2030)

Table 38 North America Oral Insulin Revenue (USD Million) By Type (2023-2030)

Table 39 North America Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Oral Insulin Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Oral Insulin Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Oral Insulin Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Oral Insulin Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Oral Insulin Revenue (USD Million) By Country (2023-2030)

Table 47 South America Oral Insulin Revenue (USD Million) By Type (2023-2030)

Table 48 South America Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Oral Insulin Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Oral Insulin Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Oral Insulin Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Oral Insulin Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Oral Insulin Revenue Market Share (%) By Type (2022)

Figure 5 Global Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Oral Insulin Revenue Market Share (%) By Applications (2022)

Figure 7 Global Oral Insulin Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Oral Insulin Market Share (%) By Regions (2022)

Figure 9 North America Oral Insulin Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Oral Insulin Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Oral Insulin Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Oral Insulin Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Oral Insulin Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Oral Insulin Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Oral Insulin Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Oral Insulin Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Oral Insulin Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Oral Insulin Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Oral Insulin Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Oral Insulin Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Oral Insulin Revenue Market Share (%) By Type (2030)

Figure 26 Global Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Oral Insulin Revenue Market Share (%) By Applications (2030)

Figure 28 Global Oral Insulin Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Oral Insulin Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Oral Insulin Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Oral Insulin Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Oral Insulin Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Oral Insulin Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Oral Insulin Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Oral Insulin Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Oral Insulin Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Oral Insulin Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Oral Insulin Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Oral Insulin Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Oral Insulin Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

Oral Insulin Market Segmentation

By Drug Class

• Fast-acting insulin
• Intermediate-acting insulin
• Long-acting insulin

 

By Indications  

• Type 1 diabetes               
• Type 2 diabetes

 

By End User

• Adult
• Juvenile

 

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Store

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)